Profile data is unavailable for this security.
About the company
Allgens Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-end biomedical materials and related medical device products. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)191.19m
- Net income in CNY5.11m
- Incorporated2004
- Employees202.00
- LocationAllgens Medical Technology Co Ltd#5 Kaituo RoadHaidian District, Room A305Beijing 102609ChinaCHN
- Phone+86 1 056330938
- Fax+86 1 056330939
- Websitehttp://www.allgensmed.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangzhou Jet Bio-Filtration Co Ltd | 524.26m | 70.98m | 2.05bn | 1.09k | 26.13 | 1.76 | -- | 3.92 | 0.5598 | 0.5598 | 4.13 | 8.32 | 0.3246 | 3.30 | 4.08 | 480,536.10 | 4.41 | 9.35 | 4.68 | 10.39 | 37.71 | 36.76 | 13.60 | 17.89 | 7.82 | 5.33 | 0.2333 | 29.64 | -24.06 | 17.42 | -60.34 | -8.02 | 47.32 | -- |
| Allgens Medical Technology Co Ltd | 191.19m | 5.11m | 2.39bn | 202.00 | 505.17 | 1.68 | -- | 12.48 | 0.0348 | 0.0348 | 1.45 | 10.49 | 0.1251 | 1.32 | 2.81 | 946,490.30 | 0.0232 | 7.62 | 0.0241 | 8.30 | 73.87 | 83.60 | 0.1855 | 39.05 | 24.27 | -- | 0.0333 | 5.25 | -7.68 | 12.86 | -43.04 | 10.46 | -26.12 | -- |
| Jiangsu Cowin Biotech Co Ltd | 118.17m | -144.51m | 2.59bn | 657.00 | -- | 1.69 | -- | 21.93 | -1.30 | -1.30 | 1.06 | 13.63 | 0.0667 | 1.32 | 1.43 | 179,863.40 | -8.45 | -- | -8.93 | -- | 53.54 | -- | -126.60 | -- | 13.60 | -- | 0.0214 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
| Nanjing Medlander Medical Tech Co Ltd | 380.95m | 101.15m | 2.60bn | 481.00 | 25.35 | 1.98 | -- | 6.81 | 1.02 | 1.02 | 3.86 | 13.10 | 0.2527 | 1.98 | 21.47 | 791,989.40 | 7.06 | -- | 7.76 | -- | 71.46 | -- | 27.94 | -- | 7.57 | -- | 0.0115 | -- | -9.57 | -- | -26.19 | -- | -- | -- |
| Beijing Hotgen Biotech Co Ltd | 520.50m | -67.64m | 2.80bn | 1.04k | -- | 0.8585 | -- | 5.38 | -0.7349 | -0.7349 | 5.74 | 35.25 | 0.1484 | 2.20 | 5.85 | 502,410.60 | -2.13 | 29.65 | -2.22 | 34.70 | 46.98 | 56.08 | -14.33 | 32.26 | 8.95 | -- | 0.0026 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 456.90k | 0.44% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024 | 257.09k | 0.25% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2024 | 113.42k | 0.11% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 70.00k | 0.07% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 62.40k | 0.06% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 54.50k | 0.05% |
| Gfund Management Co., Ltd.as of 30 Jun 2024 | 49.31k | 0.05% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2024 | 33.60k | 0.03% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 27.32k | 0.03% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2024 | 21.80k | 0.02% |
